Skip to menu Skip to content Skip to footer

A recombinant Kunjin virus replicon vaccine will protect against the growth of a tumour expressing a tumour specific antigen (1999-2000)

Experts

Emeritus Professor Robert Tindle

Emeritus Professor
School of Chemistry and Molecular Biosciences
Faculty of Science
Robert Tindle
Robert Tindle